Prevalence of FVR506Q and prothrombin 20210A mutations in the Navarrese population
Zabalegui, N.; Montes, R.; Orbe, J.; Ayape, M.L.; Medarde, A.; Páramo, J.A.; Rocha, E.
Thrombosis and Haemostasis 80(3): 522-523
1998
ISSN/ISBN: 0340-6245 PMID: 9759640 Document Number: 496013
Document emailed within 1 workday
Related Documents
Olafsson, I.; Hjaltadóttir, S.; Onundarson, P.T.; Pórarinsdóttir, R.; Haraldsdóttir, V. 1998: Prevalence of factor V(Q506) and prothrombin 20210 a mutations in an apparently healthy Icelandic population and patients suffering from venous thrombosis Thrombosis and Haemostasis 79(3): 685-686Akhavan, S.; Lavoretano, S.; Chantarangkul, V.; Mannucci, P.M. 2002: Plasma prothrombin levels are not associated with mutations in the promoter region of the prothrombin gene Thrombosis and Haemostasis 88(5): 877-878
Torres Rivera, B.; Vallés, V.; Ríos Olivares, E. 2002: Prevalence of primary and secondary resistant mutations to antiretroviral drug in a population of Puerto Rican infected with HIV Puerto Rico Health Sciences Journal 21(4): 329-336
Takeda, Y. 1970: Studies of the effects of heparin, Coumadin, and vitamin K on prothrombin metabolism and distribution in calves with the use of iodine-125-prothrombin. Characterization of the prothrombin system Journal of Laboratory and Clinical Medicine 75(3): 355-381
Poort, S.R.; Landolfi, R.; Bertina, R.M. 1997: Compound heterozygosity for two novel missense mutations in the prothrombin gene in a patient with a severe bleeding tendency Thrombosis and Haemostasis 77(4): 610-615
Mandavilli, B.; Shoup, R.M.; DiGiuseppe, J.A.; Rezuke, W.N.; Tsongalis, G.J. 2000: Concurrent factor V Leiden and prothrombin G20210A gene mutations in a patient with a history of recurrent thrombosis Connecticut Medicine 64(5): 259-261
Ono, M.; Ohta, H.; Ohhira, M.; Sekiya, C.; Namiki, M. 1990: Measurement of immunoreactive prothrombin, des-gamma-carboxy prothrombin, and vitamin K in human liver tissues: overproduction of immunoreactive prothrombin in hepatocellular carcinoma American Journal of Gastroenterology 85(9): 1149-1154
Taylor, S.M.; Meshnick, S.R.; Worodria, W.; Andama, A.; Cattamanchi, A.; Davis, J.L.; Yoo, S.D.; Byanyima, P.; Kaswabuli, S.; Goodman, C.D.; Huang, L. 2012: Low prevalence of Pneumocystis pneumonia (PCP) but high prevalence of pneumocystis dihydropteroate synthase (dhps) gene mutations in HIV-infected persons in Uganda Plos one 7(11): E49991
Tamburrini, E.; Tumbarello, M.; Vichi, F.; Spedini, G.; Bailly, C. 1987: Prevalenza di infezioni da protozoi ed elminti in una popolazione del Cameroun Sud-Occidentale - Prévalence des infections par protozoaires et helmithes dans une population du sud ouest du Cameroun - Prevalence of protozoan and helminthic diseases in a population of the southwest Cameroon Rivista di Parassitologia 4(2): 259-273
Rao, L.V.; Hoang, A.D.; Rapaport, S.I. 1995: Differences in the interactions of lupus anticoagulant IgG with human prothrombin and bovine prothrombin Thrombosis and Haemostasis 73(4): 668-674
Jaekel H.-P.; Trabandt A.; Schmid D.; Grobe N.; Müller E.-W.; Ziutelis V.; Kaskel-Paul S.; Höh H.; Bauer B.; Sudik R.; Baldauf A.; Werle E. 2004: Autoantibodies to Prothrombin and Phosphatidylserine/Prothrombin-Complexes: Do they contribute to the Serodiagnosis of Primary and Secondary Anti-Phospholipid Syndrome? Clinical Laboratory 50(5-6): 295-304
Degen, S.J.; McDowell, S.A.; Sparks, L.M.; Scharrer, I. 1995: Prothrombin Frankfurt: a dysfunctional prothrombin characterized by substitution of Glu-466 by Ala Thrombosis and Haemostasis 73(2): 203-209
Souto, J.C.; Coll, I.; Llobet, D.; del Río, E.; Oliver, A.; Mateo, J.; Borrell, M.; Fontcuberta, J. 1998: The prothrombin 20210A allele is the most prevalent genetic risk factor for venous thromboembolism in the Spanish population Thrombosis and Haemostasis 80(3): 366-369
Fortes, F.; Dimbu, R.; Figueiredo, P.; Neto, Z.; do Rosário, V.íl.E.; Lopes, D. 2011: Evaluation of prevalence's of pfdhfr and pfdhps mutations in Angola Malaria Journal 10: 22
Desgrées du Loû, A.; Msellati, P.; La Ruche, G.; Welffens-Ekra, C.; Ramon, R.; Dabis, F. 1999: Estimation of HIV-1 prevalence in the population of Abidjan by adjustment of the prevalence observed in antenatal centres Aids 13(4): 526-527
Cubano, L.A.; Sepúlveda-Torres, L.d.C.; Sosa, G.; Boukli, N.; Robles, R.; Rodriguez, J.é W.; Guzmán, L.; Ríos-Olivares, E. 2008: Prevalence of drug resistance and associated mutations in HIV-positive Puerto Ricans: sex variations Ethnicity and Disease 18(2 Suppl 2: S2
Dean, J.; Ta Thi, T.H.; Dunford, L.; Carr, M.J.; Nguyen, L.T.; Coughlan, S.; Connell, J.; Nguyen, H.T.; Hall, W.W.; Nguyen Thi, L.A. 2011: Prevalence of HIV type 1 antiretroviral drug resistance mutations in Vietnam: a multicenter study Aids Research and Human Retroviruses 27(7): 797-801
Almeida, F.áv.J.; Rodrigues, R.; Zaparoli, M.S.; Berezin, E.N.; Sáfadi, M.A.él.P.; de Paula Ferreira, J.ão.L.; Lança, A.é M.; de Macedo Brígido, L.F. 2012: Prevalence of transmitted HIV-1 drug resistance mutations in children and adolescents in São Paulo, Brazil Pediatric Infectious Disease Journal 31(12): E255-E257
Ferec, C.; Guillermit, H.; Chaventre, A. 1991: Gene mutations of cystic fibrosis in Brittany population Pathologie-Biologie 39(6): 577-580
Gehrisch, S.; Steinke, M.; Kostka, H.; Hoche, I.; Julius, U.; Jaross, W. 1996: Point mutations in lipoprotein lipase (LPL) gene: prevalence in normal and combined hyperlipidemic subjects Zeitschrift für Gastroenterologie 34(Suppl 3): 64-65